Credo (CRDO) Director Lip‑Bu Tan Reports 25,000‑Share Sale on Form 4
Rhea-AI Filing Summary
Reporting person Lip-Bu Tan (a Credo Technology Group Holding Ltd director) reported two open-market sales on 09/12/2025 totaling 25,000 ordinary shares sold in multiple trades at weighted average prices of $161.5278 and $162.3665. The filing shows the sales reduced two indirect holdings to 455,608 and 442,180 shares respectively. The report also discloses additional indirect holdings of 133,583 shares (Lip-Bu Tan and Ysa Loo Trust) and 39,736 shares (A&E Investment LLC), plus 53,574 shares held directly. The form includes explanations of price ranges and updated entity names for the disclosed funds.
Positive
- Transparent disclosure of open-market sales with weighted average prices and price ranges provided
- Detailed attribution of indirect holdings (venture GP/LP, trust, LLC) and clarification of updated entity names
Negative
- Insider sold 25,000 shares across two transactions on 09/12/2025 (may be viewed negatively by some investors)
- No explanation provided in the filing for the reason behind the sales
Insights
TL;DR: Director executed routine open-market sales of 25,000 shares across two transactions; remaining holdings remain substantial.
The Form 4 documents two separate sales on 09/12/2025 totaling 25,000 shares executed in multiple trades with weighted average prices reported as $161.5278 and $162.3665. Ownership tables indicate sizable indirect positions held via venture and trust entities and a direct holding of 53,574 shares. The filing supplies transaction price ranges and clarifies updated entity names for the venture vehicles. This disclosure is transactional and informational; no new corporate events or changes to governance are reported.
TL;DR: Insider sale disclosed with clear attribution to indirect entities and trustee roles; no governance changes reported.
The report identifies the reporting person as a director and discloses roles (managing director, joint trustee, manager) tied to indirect holdings. Sales were executed via open-market trades and documented with weighted average prices and price ranges as required. The Form 4 updates names for the venture entities previously used in filings. There is no disclosure of resignations, option exercises, or related-party transactions beyond the sales and entity clarifications.